Steven W. Lefkowitz - 12 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol
CRMD
Transactions as of
12 Jan 2026
Net transactions value
+$84,450
Form type
4
Filing time
14 Jan 2026, 21:30:02 UTC
Previous filing
10 Dec 2025
Next filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lefkowitz Steven W Director C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Beth Zelnick Kaufman, attorney-in-fact 14 Jan 2026 0001313149

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $84,450 +15,000 +19% $5.63 95,498 12 Jan 2026 Direct F1
holding CRMD Common Stock 30,152 12 Jan 2026 Wade Capital Corporation Money Purchase Plan F2
holding CRMD Common Stock 2,000 12 Jan 2026 Reporting Person's Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -15,000 -100% $0.000000 0 12 Jan 2026 Common Stock 15,000 $5.63 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made.
F2 The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
F3 These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested.

Remarks:

Exhibit 24.1 - Power of Attorney